Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutiform vs Seretide in Asthma Small Airway Parameters
NCT02491970Phase 4Terminated
- Sponsor
- Mundipharma
- Start
- Aug 2015
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, single-blind trial of fluticasone propionate + formoterol in asthma (2 arms), sponsored by Mundipharma. Primary endpoint: Efficacy superiority as measured by Impulse Oscillometric System at 12 weeks. Started Aug 2015; status: terminated.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02491970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491970.